"Bromocriptine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.
| Descriptor ID |
D001971
|
| MeSH Number(s) |
D03.132.327.412.100 D03.633.400.439.131 D03.633.400.562.100
|
| Concept/Terms |
Bromocriptine- Bromocriptine
- 2-Bromo-alpha-ergokryptine
- 2 Bromo alpha ergokryptine
- Bromocryptin
- 2-Bromoergokryptine
- 2 Bromoergokryptine
- Bromocriptin
- 2-Bromoergocryptine
- 2 Bromoergocryptine
- 2-Bromo-alpha-ergocryptine
- 2 Bromo alpha ergocryptine
2-Bromoergocryptine Mesylate- 2-Bromoergocryptine Mesylate
- 2 Bromoergocryptine Mesylate
- Mesylate, 2-Bromoergocryptine
- Bromocriptine Mesylate
- Mesylate, Bromocriptine
- 2-Bromoergocryptine Methanesulfonate
- 2 Bromoergocryptine Methanesulfonate
- Methanesulfonate, 2-Bromoergocryptine
|
Below are MeSH descriptors whose meaning is more general than "Bromocriptine".
Below are MeSH descriptors whose meaning is more specific than "Bromocriptine".
This graph shows the total number of publications written about "Bromocriptine" by people in this website by year, and whether "Bromocriptine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bromocriptine" by people in Profiles.
-
Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane. Nature. 2020 08; 584(7819):125-129.
-
Endonasal endoscopic transsphenoidal chiasmapexy using a clival cranial base cranioplasty for visual loss from massive empty sella following macroprolactinoma treatment with bromocriptine: case report. J Neurosurg. 2016 Apr; 124(4):1025-31.
-
The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations. Endocr Pract. 2013 Jan-Feb; 19(1):100-6.
-
Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst Rev. 2010 Dec 08; (12):CD007747.
-
Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection. Pituitary. 2009; 12(3):158-64.
-
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007 Feb 09; 128(3):589-600.
-
Activation of D2-like receptors causes recruitment of tyrosine-phosphorylated NKA alpha 1-subunits in kidney. Am J Physiol Renal Physiol. 2002 Dec; 283(6):F1290-5.
-
Role of tyrosine kinase and p44/42 MAPK in D(2)-like receptor-mediated stimulation of Na(+), K(+)-ATPase in kidney. Am J Physiol Renal Physiol. 2002 Apr; 282(4):F697-702.
-
Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs Aging. 2001; 18(6):389-96.
-
Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. J Endocrinol Invest. 1992 Mar; 15(3):185-90.